Found: 12
Select item for more details and to access through your institution.
Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
- Published in:
- European Heart Journal, 2023, v. 44, n. 47, p. 4935, doi. 10.1093/eurheartj/ehad666
- By:
- Publication type:
- Article
Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood Markers.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1642, doi. 10.3390/vaccines11111642
- By:
- Publication type:
- Article
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1469, doi. 10.3390/vaccines11091469
- By:
- Publication type:
- Article
SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform.
- Published in:
- Antibodies (2073-4468), 2022, v. 11, n. 4, p. 76, doi. 10.3390/antib11040076
- By:
- Publication type:
- Article
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.981532
- By:
- Publication type:
- Article
Non-HLA Antibodies in Hand Transplant Recipients Are Connected to Multiple Acute Rejection Episodes and Endothelial Activation.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 3, p. 833, doi. 10.3390/jcm11030833
- By:
- Publication type:
- Article
Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1353, doi. 10.3390/vaccines9111353
- By:
- Publication type:
- Article
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72960-1
- By:
- Publication type:
- Article
GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07598-9
- By:
- Publication type:
- Article
Comparative Assessment of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG Gene Fusion with the Serum [-2]Proprostate-Specific Antigen-Based Prostate Health Index for Detection of Prostate Cancer.
- Published in:
- Clinical Chemistry, 2013, v. 59, n. 1, p. 280, doi. 10.1373/clinchem.2012.195560
- By:
- Publication type:
- Article
Cells on a Chip - the Use of Electric Properties for Highly Sensitive Monitoring of Blood-Derived Factors Involved in Angiotensin II Type 1 Receptor Signalling.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2005, v. 16, n. 1-3, p. 051, doi. 10.1159/000087731
- By:
- Publication type:
- Article